Skip to search formSkip to main contentSkip to account menu

Oncotype DX Breast Cancer Assay

Known as: Oncotype DX 
A diagnostic assay that quantifies the likelihood of breast cancer recurrence in women with newly diagnosed, early stage breast cancer. In addition… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Multigene Signature Panels and Breast Cancer Therapy: Patterns of Use and Impact on Clinical Decision Making.
2017
2017
The value of algorithms predicting the Oncotype DX recurrence score should not be underestimated!
Review
2016
Review
2016
Influence of a 21-Gene Recurrence Score Assay on Chemotherapy Delivery in Breast Cancer.
2016
2016
Breast cancer specific survival in patients with node-positive hormone receptor positive invasive breast cancer and Oncotype DX recurrence score results in the SEER database.
6575Background: The 21-tumor gene expression assay has been shown to predict breast cancer recurrence and adjuvant chemotherapy… 
2016
2016
Association between partial-volume corrected SUVmax and Oncotype DX recurrence score in early-stage, ER-positive/HER2-negative invasive breast cancer
PurposeOncotype DX, a 21-gene expression assay, provides a recurrence score (RS) which predicts prognosis and the benefit from… 
2015
2015
Racial variation in adjuvant chemotherapy initiation among breast cancer patients receiving oncotype DX testing
It is unknown whether racial differences exist in adjuvant chemotherapy initiation among women with similar oncotype DX (ODX… 
Review
2015
Review
2015
Menopausal status does not predict Oncotype DX recurrence score.
Review
2014
Review
2014
Oncotype Dx Results in Multiple Primary Breast Cancers
Purpose To determine whether multiple primary breast cancers have similar genetic profiles, specifically Oncotype Dx Recurrence… 
2014
2014
The Clinical Impact of 21-Gene Recurrence Score on Treatment Decisions for Patients with Hormone Receptor-Positive Early Breast Cancer in Korea
Purpose The 21-gene (Oncotype DX) recurrence score (RS) assay is useful in predicting the benefits of adjuvant chemotherapy for… 
Review
2007
Review
2007
How well do standard prognostic criteria predict oncotype DX (ODX) scores
576 Background: In node-negative, ER + breast cancer, gene expression profiling can identify level of risk and, in the case of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)